Oaktree Acquisition III Life Sciences Corp

Oaktree Acquisition III Life Sciences Corp (OACC) Stock Analysis

$10.720

0.000 (0.00%)At close

Loading chart…
High
10.720
Open
10.720
VWAP
10.72
Volume
18.00
Mkt Cap
—
Low
10.720
Amount
192.96
EV/EBITDA, TTM
0.00

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues.

AI analysis of Oaktree Acquisition III Life Sciences Corp (OACC)

Hold

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

Valuation Metrics

The current forward P/E ratio for Oaktree Acquisition III Life Sciences Corp (OACC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Fair
5Y Average P/S
0.06
Current P/S
0.00
Overvalued
0.84
Undervalued
-0.72

Alphio AI Price Scenarios for OACC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%OACC

$12.28

Scenario price

B

Base

Base · 50%OACC

$11.50

Scenario price

B

Bear

Bear · 25%OACC

$10.82

Scenario price

Whales holding OACC

E

Empyrean Capital Partners, LP

+ HoldingOACC

-3.81%

3M Return

OACC FAQ — answered by Alphio AI

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues. It operates in the Financials sector.

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading